Humacyte (HUMA) Change in Acquisitions & Divestments (2022)
Humacyte (HUMA) reported Change in Acquisitions & Divestments of $8.0 million for Q4 2022.
Humacyte (HUMA) Change in Acquisitions & Divestments (2022) Analysis & Trends
Humacyte (HUMA) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $8.0 million in Q4 2022.
- Change in Acquisitions & Divestments for Q4 2022 came in at $8.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $8.0 million (changed 0.0% YoY), and the FY2023 annual result was $2.1 million, down 86.83% from the prior year.
- Change in Acquisitions & Divestments steadied at $8.0 million in Q4 2022 per HUMA's latest filing.
- Over five years, Change in Acquisitions & Divestments peaked at $8.0 million in Q4 2022 and troughed at $8.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Humacyte | 183.21 Mn | 134.67 Mn | -1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 8.00 Mn |
| Dec 31, 2022 | 8.00 Mn |